Roche suffers trial setback
Multinational healthcare giant Roche suffered a setback recently, after it was revealed geographic atrophy (GA) drug lampalizumab did not meet ...
Multinational healthcare giant Roche suffered a setback recently, after it was revealed geographic atrophy (GA) drug lampalizumab did not meet ...
Biotech company Aldeyra Therapeutics saw its share price soar recently, following the positive outcome of its Phase 2A trials of ...
Two Korean pharmaceutical companies have filed an investigational new drug application with the USFDA to conduct phase 2 clinical trials ...
In a first for the region, Western Pacific countries Cambodia and Laos have been able to eliminate trachoma as a ...
Doctors in Mexico made a gruesome discovery recently, when they found a live flatworm inside the eyeball of a 17-year-old ...
Allergan has gone to unusual lengths to protect its best-selling eye drug Restasis against challenges from companies that produce generic ...
The American Optometric Association (AOA) has expressed disappointment and concern over new recommendations from the US Preventative Services Task Force ...
Visit Alcon-Novartis Pharmaceuticals' Showroom
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited